2015 Article Archive
UT Southwestern Medical Center researchers have developed a classification for cancers caused by KRAS, the most frequently mutated gene in cancer, that could eventually help oncologists choose more effective, customized cancer therapies.
William P. Clements Jr. University Hospital garners national quality and safety award for academic medical centers
Rising Star Quality Leadership award identifies exemplary performance in patient safety, mortality, clinical effectiveness, and equity of care among academic medical centers.
Dr. William Israelsen, a UT Southwestern Medical Center research scientist whose studies on hibernation may aid the fight against cancer, today became one of 16 investigators chosen for a National Institutes of Health Early Independence Award.
UT Southwestern Medical Center today announced the launch of “Call Out Cancer,” a new health initiative designed to promote awareness, early detection, and prevention of all types of cancer.
The UT System Board of Regents approved the creation of an integrated regional health network (Integrated Network) including the UT Southwestern Medical Center and Texas Health Resources (Texas Health) systems.
Dr. Walter L. “Pete” Peterson Jr., Professor Emeritus of Internal Medicine at UT Southwestern Medical Center, died on Aug. 6 at a Houston assisted living center, of progressive supranuclear palsy, a rare brain disease. He was 72.
The Department of Ophthalmology has received a grant from Research to Prevent Blindness to support the early-career eye disease research of Dr. John Hulleman, Assistant Professor of Ophthalmology.
Federal, nonfederal, and industry-sponsored grants awarded to UT Southwestern faculty in August 2015.
UT Southwestern Medical Center geneticist Dr. Helen Hobbs is the 2015 recipient of the prestigious Pearl Meister Greengard Prize. The prize recognizes Dr. Hobbs’ research, which advances understanding of heart disease and other complex disorders.
Immunotherapy superior to chemotherapy for lung cancer in international trial involving cancer researchers
An international team of cancer researchers that included UT Southwestern Medical Center physicians announced “game-changing results” using the immunotherapy drug nivolumab to treat certain lung cancers that failed to respond to first-line therapies.